These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8680379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI, Bush A, Canny GJ, Colin AA, Fuchs HJ, Geddes DM, Johnson CA, Light MC, Scott SF, Tullis DE.
    Eur Respir J; 1995 Jun; 8(6):954-8. PubMed ID: 7589382
    [Abstract] [Full Text] [Related]

  • 3. DNase trials in cystic fibrosis.
    Hodson ME, Shah PL.
    Eur Respir J; 1995 Oct; 8(10):1786-91. PubMed ID: 8586138
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations.
    Wilmott RW, Amin RS, Colin AA, DeVault A, Dozor AJ, Eigen H, Johnson C, Lester LA, McCoy K, McKean LP, Moss R, Nash ML, Jue CP, Regelmann W, Stokes DC, Fuchs HJ.
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1914-7. PubMed ID: 8665055
    [Abstract] [Full Text] [Related]

  • 12. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME.
    Thorax; 1996 Feb; 51(2):119-25. PubMed ID: 8711640
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
    Suri R.
    BioDrugs; 2005 Feb; 19(3):135-44. PubMed ID: 15984899
    [Abstract] [Full Text] [Related]

  • 16. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL, Auci RM, Shields DE, Christiansen DH, Lucas MK, Fuchs HJ, Rosenstein BJ.
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [Abstract] [Full Text] [Related]

  • 17. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].
    Hodson M.
    Arch Pediatr; 1995 Jul; 2(7):679-81. PubMed ID: 7663660
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R, Metcalfe C, Wallis C, Bush A.
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [Abstract] [Full Text] [Related]

  • 20. Clinical trials of recombinant human DNase in cystic fibrosis patients.
    Aitken ML.
    Monaldi Arch Chest Dis; 1993 Dec; 48(6):653-6. PubMed ID: 8124306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.